Themis Medicare Limited — Others, 01-08-2025: Change in Management

Themis Medicare's board has announced its Q1 financial results, reporting a standalone net loss of ₹15.37 Cr and consolidated net loss of ₹14.22 Cr, with revenues around ₹97.58 Cr. A key update is the withdrawal of the proposed merger with Gujarat Themis Biosyn Limited, allowing Themis Medicare to refocus on its core domestic formulations business. The company also announced the appointment of Ms. Neha Thakore as an Independent Director and Mr. Viraj Save as Executive President – Sales & Marketing. Shareholders should note the September 5, 2025, record date for the final dividend for the financial year ended March 31, 2025. An exceptional charge of ₹1.29 Cr was recognized due to a subsidiary's dissolution.